Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac
2004 ◽
Vol 171
(4S)
◽
pp. 311-312
◽
2004 ◽
Vol 171
(4S)
◽
pp. 280-281
◽
Keyword(s):